ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 761817 (Z)-5-methoxy-3-((1-(3,4,5-trimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.00714731931708452 0.43843454
NSC 145219 Null 0.00744479268267747 0.47107216
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.00744479268267747 0.19255901
NSC 357680 BUELLOLIDE 0.00744479268267747 0.35062965
NSC 372950 Null 0.00744479268267747 0.23452255
NSC 381866 BAFILOMYCIN DERIV. 0.00744479268267747 0.18288338
NSC 382770 Null 0.00744479268267747 0.38231398
NSC 404027 Null 0.00744479268267747 0.32389509
NSC 620077 Null 0.00744479268267747 0.29941431
NSC 633781 1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate 0.00744479268267747 0.00085088769
Total:136  Current:43    [First] [Prev] [Next] [Last]